MeasuredReferenceTivozanib targets RET, C_KIT, KDR_VEGFR2. Strongest hallmark effect: tumor promoting inflammation.
Top hallmarks
- tumor promoting inflammation4.5k
- evading apoptosis3.6k
- proliferation3.4k
Top pathways disrupted
- apical junction9.9k
- allograft rejection9.3k
- pi3k akt mtor signaling9.1k
Resistance landscape — Tivozanib
MeasuredReference10 known oncogenic variants exist on Tivozanib's top targets — see detail for inhibition impact.